Rediscovering denosumab: From osteoporosis medication to a possible treatment for breast cancer

Rediscovering denosumab: From osteoporosis medication to a possible treatment for breast cancer

Science and society collaboration is essential for scientific progress, especially in the health and biomedical fields where basic researchers, clinicians and patients are involved, as shown by the initial results of D-BIOMARK. This clinical trial against breast cancer has analyzed the potential anti-tumor role of denosumab, a drug already in use in the prevention of metastasis-related osteoporosis and bone lesions.